Annual Total Liabilities
$19.07 M
+$4.42 M+30.18%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual total liabilities is $19.07 million, with the most recent change of +$4.42 million (+30.18%) on April 30, 2024.
- During the last 3 years, IPA annual total liabilities has risen by +$10.90 million (+133.33%).
- IPA annual total liabilities is now at all-time high.
Performance
IPA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$19.62 M
+$525.10 K+2.75%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly total liabilities is $19.62 million, with the most recent change of +$525.10 thousand (+2.75%) on October 31, 2024.
- Over the past year, IPA quarterly total liabilities has increased by +$525.10 thousand (+2.75%).
- IPA quarterly total liabilities is now -8.92% below its all-time high of $21.54 million, reached on January 31, 2024.
Performance
IPA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
IPA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.2% | +2.8% |
| 3 y3 years | +133.3% | +2.8% |
| 5 y5 years | +146.9% | +2.8% |
IPA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +133.3% | -8.9% | +185.8% |
| 5 y | 5-year | at high | +146.9% | -8.9% | +185.8% |
| alltime | all time | at high | >+9999.0% | -8.9% | >+9999.0% |
ImmunoPrecise Antibodies Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $19.62 M(+2.8%) |
| Jul 2024 | - | $19.09 M(+0.1%) |
| Apr 2024 | $19.07 M(+30.2%) | $19.07 M(-11.5%) |
| Jan 2024 | - | $21.54 M(+26.4%) |
| Oct 2023 | - | $17.05 M(-0.6%) |
| Jul 2023 | - | $17.15 M(+17.1%) |
| Apr 2023 | $14.65 M(+3.3%) | $14.65 M(-8.2%) |
| Jan 2023 | - | $15.96 M(+3.3%) |
| Oct 2022 | - | $15.44 M(+46.1%) |
| Jul 2022 | - | $10.57 M(-25.5%) |
| Apr 2022 | $14.19 M(+73.6%) | $14.19 M(+106.7%) |
| Jan 2022 | - | $6.86 M(-9.8%) |
| Oct 2021 | - | $7.61 M(+5.5%) |
| Jul 2021 | - | $7.21 M(-11.8%) |
| Apr 2021 | $8.17 M(-6.0%) | $8.17 M(-7.9%) |
| Jan 2021 | - | $8.87 M(-6.4%) |
| Oct 2020 | - | $9.48 M(-5.9%) |
| Jul 2020 | - | $10.07 M(+15.7%) |
| Apr 2020 | $8.70 M(+12.6%) | $8.70 M(+3.5%) |
| Jan 2020 | - | $8.41 M(-5.9%) |
| Oct 2019 | - | $8.94 M(-3.4%) |
| Jul 2019 | - | $9.25 M(+19.8%) |
| Apr 2019 | $7.72 M(-16.4%) | $7.72 M(+11.8%) |
| Jan 2019 | - | $6.91 M(-12.9%) |
| Oct 2018 | - | $7.93 M(-11.2%) |
| Jul 2018 | - | $8.93 M(-3.4%) |
| Apr 2018 | $9.24 M(+1405.7%) | $9.24 M(+288.2%) |
| Jan 2018 | - | $2.38 M(+14.9%) |
| Oct 2017 | - | $2.07 M(+377.8%) |
| Jul 2017 | - | $433.80 K(-29.3%) |
| Apr 2017 | $613.90 K(+233.1%) | $613.90 K(+8.3%) |
| Jan 2017 | - | $566.60 K(+208.6%) |
| Sep 2016 | - | $183.60 K(-1.5%) |
| Jun 2016 | - | $186.40 K(-6.8%) |
| Mar 2016 | - | $199.90 K(+8.5%) |
| Dec 2015 | $184.30 K(-16.0%) | - |
| Dec 2015 | - | $184.30 K(+3.2%) |
| Sep 2015 | - | $178.50 K(-7.5%) |
| Jun 2015 | - | $192.90 K(-5.9%) |
| Mar 2015 | - | $205.00 K(-6.6%) |
| Dec 2014 | $219.40 K(-23.0%) | - |
| Dec 2014 | - | $219.40 K(-9.0%) |
| Sep 2014 | - | $241.20 K(-10.8%) |
| Jun 2014 | - | $270.30 K(+4.0%) |
| Mar 2014 | - | $260.00 K(-8.8%) |
| Dec 2013 | $285.00 K(+6.7%) | - |
| Dec 2013 | - | $285.00 K(+2.6%) |
| Sep 2013 | - | $277.90 K(+1.1%) |
| Jun 2013 | - | $274.80 K(+3.6%) |
| Mar 2013 | - | $265.30 K(-0.6%) |
| Dec 2012 | $267.00 K(+27.9%) | - |
| Dec 2012 | - | $267.00 K(+10.7%) |
| Sep 2012 | - | $241.30 K(+9.3%) |
| Jun 2012 | - | $220.70 K(-5.3%) |
| Mar 2012 | - | $233.10 K(+11.7%) |
| Dec 2011 | $208.70 K(+89.4%) | - |
| Dec 2011 | - | $208.70 K(+17.5%) |
| Sep 2011 | - | $177.60 K(+39.3%) |
| Jun 2011 | - | $127.50 K(+45.4%) |
| Mar 2011 | - | $87.70 K(-20.4%) |
| Dec 2010 | $110.20 K | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | $110.20 K(-38.3%) |
| Sep 2010 | - | $178.50 K(+75.3%) |
| Jun 2010 | - | $101.80 K(+2.9%) |
| Mar 2010 | - | $98.90 K(+6.5%) |
| Dec 2009 | $92.90 K(-24.1%) | - |
| Dec 2009 | - | $92.90 K(+72.4%) |
| Sep 2009 | - | $53.90 K(+11.4%) |
| Jun 2009 | - | $48.40 K(-18.5%) |
| Mar 2009 | - | $59.40 K(-51.5%) |
| Dec 2008 | $122.40 K(+226.4%) | - |
| Dec 2008 | - | $122.40 K(-65.4%) |
| Sep 2008 | - | $353.30 K(+369.8%) |
| Jun 2008 | - | $75.20 K(+158.4%) |
| Mar 2008 | - | $29.10 K(-22.4%) |
| Dec 2007 | $37.50 K(-89.4%) | - |
| Dec 2007 | - | $37.50 K(+30.2%) |
| Sep 2007 | - | $28.80 K(-50.6%) |
| Jun 2007 | - | $58.30 K(-56.8%) |
| Mar 2007 | - | $135.00 K(-61.9%) |
| Dec 2006 | $354.70 K(+197.3%) | - |
| Dec 2006 | - | $354.70 K(-29.0%) |
| Sep 2006 | - | $499.90 K(+1003.5%) |
| Jun 2006 | - | $45.30 K(+6.3%) |
| Mar 2006 | - | $42.60 K(-64.3%) |
| Dec 2005 | $119.30 K(+203.6%) | - |
| Dec 2005 | - | $119.30 K(-79.0%) |
| Sep 2005 | - | $568.90 K(+84.5%) |
| Jun 2005 | - | $308.30 K(+978.0%) |
| Mar 2005 | - | $28.60 K(-27.2%) |
| Dec 2004 | $39.30 K(+2.3%) | - |
| Dec 2004 | - | $39.30 K(-59.4%) |
| Sep 2004 | - | $96.80 K(+11.8%) |
| Jun 2004 | - | $86.60 K(+274.9%) |
| Mar 2004 | - | $23.10 K(-39.8%) |
| Dec 2003 | $38.40 K(+105.3%) | - |
| Dec 2003 | - | $38.40 K(-61.5%) |
| Sep 2003 | - | $99.80 K(+309.0%) |
| Jun 2003 | - | $24.40 K(+123.9%) |
| Mar 2003 | - | $10.90 K(-41.7%) |
| Dec 2002 | $18.70 K(-84.1%) | - |
| Dec 2002 | - | $18.70 K(+57.1%) |
| Sep 2002 | - | $11.90 K(-42.5%) |
| Jun 2002 | - | $20.70 K(-86.8%) |
| Mar 2002 | - | $156.60 K(+33.3%) |
| Dec 2001 | $117.50 K(-80.3%) | - |
| Dec 2001 | - | $117.50 K(-0.5%) |
| Sep 2001 | - | $118.10 K(-17.2%) |
| Jun 2001 | - | $142.60 K(-72.5%) |
| Mar 2001 | - | $518.50 K(-13.2%) |
| Dec 2000 | $597.50 K(+8435.7%) | - |
| Dec 2000 | - | $597.50 K(+446.2%) |
| Sep 2000 | - | $109.40 K(+145.3%) |
| Jun 2000 | - | $44.60 K(+309.2%) |
| Mar 2000 | - | $10.90 K(+55.7%) |
| Dec 1999 | $7000.00(-69.7%) | - |
| Dec 1999 | - | $7000.00(-69.7%) |
| Dec 1998 | $23.10 K(-50.9%) | - |
| Dec 1998 | - | $23.10 K(-50.9%) |
| Dec 1997 | $47.00 K(-74.2%) | - |
| Dec 1997 | - | $47.00 K |
| Dec 1996 | $182.50 K | - |
FAQ
- What is ImmunoPrecise Antibodies annual total liabilities?
- What is the all time high annual total liabilities for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual total liabilities year-on-year change?
- What is ImmunoPrecise Antibodies quarterly total liabilities?
- What is the all time high quarterly total liabilities for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly total liabilities year-on-year change?
What is ImmunoPrecise Antibodies annual total liabilities?
The current annual total liabilities of IPA is $19.07 M
What is the all time high annual total liabilities for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual total liabilities is $19.07 M
What is ImmunoPrecise Antibodies annual total liabilities year-on-year change?
Over the past year, IPA annual total liabilities has changed by +$4.42 M (+30.18%)
What is ImmunoPrecise Antibodies quarterly total liabilities?
The current quarterly total liabilities of IPA is $19.62 M
What is the all time high quarterly total liabilities for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly total liabilities is $21.54 M
What is ImmunoPrecise Antibodies quarterly total liabilities year-on-year change?
Over the past year, IPA quarterly total liabilities has changed by +$525.10 K (+2.75%)